IL6 and viral infectious disease: Since proinflammatory cytokines such as TNF-α and IL-6 are also crucial for host control of bacterial and viral infections, therapeutic interventions that selectively target these cytokines are associated with adverse side effects, including delayed pathogen clearance, hypotension, multi-organ dysfunction, and reactivation of secondary infections such as M. tuberculosis infection (72).